Lack of strong effect modification by NFE2L2/CYP3A5/ABO of the risk of venous thrombosis associated with oral hormone therapy

Documenti analoghi

• The association of smoking with venous thrombosis in women: a population-based, case-control study
  di: Blondon, M., et al.
  Pubblicazione: (2013)
• ABO Genotype and Risk of Thrombotic Events and Hemorrhagic Stroke
  di: Wiggins, KL, et al.
  Pubblicazione: (2008)
• Differential associations of oral estradiol and conjugated equine estrogen with hemostatic biomarkers
  di: Blondon, M., et al.
  Pubblicazione: (2014)
• The Association of Statin Therapy with the Risk of Recurrent Venous Thrombosis
  di: Smith, Nicholas L., et al.
  Pubblicazione: (2016)
• Vasomotor symptoms and the risk of incident venous thrombosis in postmenopausal women
  di: Harrington, L.B., et al.
  Pubblicazione: (2018)